Lynparza/Recentin Combo Fails In Phase III PSR Ovarian Cancer

Disappointment For AstraZeneca

 
• By Alexandra Shimmings
  
Ovarian cancer
Ovarian cancer is difficult to treat • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D